Aflac Incorporated (LON:0H68)
London flag London · Delayed Price · Currency is GBP · Price in USD
104.29
+0.69 (0.67%)
At close: Jul 3, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
-
Log In
Log In
Log In
Log In
Upgrade
Japan Cancer Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
Japan Cancer Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
Japan Medical & Other Health Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
Japan Medical & Other Health Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
Japan Life Insurance Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
Japan Life Insurance Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Cancer Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
US Cancer Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Other Health Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
US Other Health Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Life Insurance Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
US Life Insurance Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Accident Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
US Accident Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Disability Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
US Disability Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Critical Care Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
US Critical Care Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Hospital Indemnity Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
US Hospital Indemnity Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Dental/Vision Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
US Dental/Vision Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Other Net Earned Premiums
-
Log In
Log In
Log In
Log In
Upgrade
US Other Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
Total Japan Net Earned Premiums
6.93B
Log In
Log In
Log In
Log In
Upgrade
Total Japan Net Earned Premiums Growth
-11.69%
Log In
Log In
Log In
Log In
Upgrade
Japan Adjusted Net Investment Income
2.70B
Log In
Log In
Log In
Log In
Upgrade
Japan Adjusted Net Investment Income Growth
0.73%
Log In
Log In
Log In
Log In
Upgrade
Japan Other Income
28.00M
Log In
Log In
Log In
Log In
Upgrade
Japan Other Income Growth
-20.59%
Log In
Log In
Log In
Log In
Upgrade
Total US Net Earned Premiums
5.83B
Log In
Log In
Log In
Log In
Upgrade
Total US Net Earned Premiums Growth
2.36%
Log In
Log In
Log In
Log In
Upgrade
US Adjusted Net Investment Income
847.00M
Log In
Log In
Log In
Log In
Upgrade
US Adjusted Net Investment Income Growth
1.69%
Log In
Log In
Log In
Log In
Upgrade
US Other Income
63.00M
Log In
Log In
Log In
Log In
Upgrade
US Other Income Growth
-45.95%
Log In
Log In
Log In
Log In
Upgrade
Corporate
1.01B
Log In
Log In
Log In
Log In
Upgrade
Corporate Growth
87.54%
Log In
Log In
Log In
Log In
Upgrade
Net Investment Gains
1.27B
Log In
Log In
Log In
Log In
Upgrade
Net Investment Gains Growth
-145.35%
Log In
Log In
Log In
Log In
Upgrade
Amortized Hedge Costs
26.00M
Log In
Log In
Log In
Log In
Upgrade
Amortized Hedge Costs Growth
-73.08%
Log In
Log In
Log In
Log In
Upgrade
Amortized Hedge Income
-113.00M
Log In
Log In
Log In
Log In
Upgrade
Amortized Hedge Income Growth
-5.00%
Log In
Log In
Log In
Log In
Upgrade
Net Interest Cash Flows from Derivatives
338.00M
Log In
Log In
Log In
Log In
Upgrade
Net Interest Cash Flows from Derivatives Growth
-11.85%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Japan Cancer Net Earned Premiums (Post-FY2023 Reporting)
3.55B
Log In
Log In
Log In
Log In
Upgrade
Japan Cancer Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Japan Medical & Other Health Net Earned Premiums (Post-FY2023 Reporting)
2.18B
Log In
Log In
Log In
Log In
Upgrade
Japan Medical & Other Health Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Japan Life Insurance Net Earned Premiums (Post-FY2023 Reporting)
1.23B
Log In
Log In
Log In
Log In
Upgrade
Japan Life Insurance Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Japan Other Net Earned Premiums (Post-FY2023 Reporting)
134.00M
Log In
Log In
Log In
Log In
Upgrade
Japan Other Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Accident Net Earned Premiums (Post-FY2023 Reporting)
1.27B
Log In
Log In
Log In
Log In
Upgrade
US Accident Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Disability Net Earned Premiums (Post-FY2023 Reporting)
1.33B
Log In
Log In
Log In
Log In
Upgrade
US Disability Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Critical Care Net Earned Premiums (Post-FY2023 Reporting)
1.76B
Log In
Log In
Log In
Log In
Upgrade
US Critical Care Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Hospital Indemnity Net Earned Premiums (Post-FY2023 Reporting)
727.00M
Log In
Log In
Log In
Log In
Upgrade
US Hospital Indemnity Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Dental/Vision Net Earned Premiums (Post-FY2023 Reporting)
202.00M
Log In
Log In
Log In
Log In
Upgrade
US Dental/Vision Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Life Insurance Net Earned Premiums (Post-FY2023 Reporting)
565.00M
Log In
Log In
Log In
Log In
Upgrade
US Life Insurance Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Other Net Earned Premiums (Post-FY2023 Reporting)
110.00M
Log In
Log In
Log In
Log In
Upgrade
US Other Net Earned Premiums (Post-FY2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Net Earned Premiums
680.00M
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
Reinsurance Ceded Net Earned Premiums
-284.00M
Log In
Log In
Log In
Log In
Upgrade
Reinsurance Ceded Net Earned Premiums Growth
-
Log In
Log In
Log In
Log In
Upgrade
Aflac Japan Net Earned Premiums
6.93B
Log In
Log In
Log In
Log In
Upgrade
Aflac Japan Net Earned Premiums Growth
-7.43%
Log In
Log In
Log In
Log In
Upgrade
Aflac U.S. Net Earned Premiums
5.83B
Log In
Log In
Log In
Log In
Upgrade
Aflac U.S. Net Earned Premiums Growth
1.83%
Log In
Log In
Log In
Log In
Upgrade
All Other Net Earned Premiums
680.00M
Log In
Log In
Log In
Log In
Upgrade
All Other Net Earned Premiums Growth
20.00%
Log In
Log In
Log In
Log In
Upgrade
Aflac Japan Premiums Written
7.87B
Log In
Log In
Log In
Log In
Upgrade
Aflac Japan Premiums Written Growth
-
Log In
Log In
Log In
Log In
Upgrade
Aflac U.S. Premiums Written
5.91B
Log In
Log In
Log In
Log In
Upgrade
Aflac U.S. Premiums Written Growth
-
Log In
Log In
Log In
Log In
Upgrade
Aflac Japan Pre-Tax Earnings
3.49B
Log In
Log In
Log In
Log In
Upgrade
Aflac Japan Pre-Tax Earnings Growth
-10.86%
Log In
Log In
Log In
Log In
Upgrade
Aflac US Pre-Tax Earnings
1.42B
Log In
Log In
Log In
Log In
Upgrade
Aflac US Pre-Tax Earnings Growth
0.56%
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Pre-Tax Earnings
32.00M
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Pre-Tax Earnings Growth
-1533.33%
Log In
Log In
Log In
Log In
Upgrade